• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy.

作者信息

Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Darú V, Valentino M, Liprandi A S, Luceri R

机构信息

Sanatorio Mitre, Buenos Aires, Argentina.

出版信息

Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 2):202-5. doi: 10.1111/j.1540-8159.1999.tb00333.x.

DOI:10.1111/j.1540-8159.1999.tb00333.x
PMID:9990631
Abstract

UNLABELLED

The time to first ICD shock has been extensively studied in patients with coronary artery disease (CAD). However, there are no published data on ICD shocks in patients with Chagas cardiomyopathy (ChC). The occurrence of the first appropriate ICD shock during the first 6 months of follow-up in 20 patients with ChC (group 1) and 35 CAD patients (group 2) was analyzed retrospectively. All patients had received a third-generation pectoral ICD for ventricular tachycardia or fibrillation (VT/VF). Indications for ICD implantation were refractoriness to drug therapy or noninducibility of VT/VF at EPS in cardiac arrest survivors.

RESULTS

The mean age, left ventricular ejection fraction (LVEF), and sex in groups I and II were 57.4 +/- 7 years versus 64 +/- 9 (P < 0.01), 30.9% +/- 10% versus 32.9% +/- 10% (P = NS), and 10 men versus 31 women (P < 0.005), respectively. Six months after ICD implantation, 85% (17/20) group I patients received appropriate ICD shocks versus 51% (18/35) in group 2, a statistically significant difference (P < 0.02, RR: 1.65, OR: 5.35).

CONCLUSIONS

The incidence of appropriate ICD shocks within the first 6 months postimplantation was significantly higher in ChC patients than in CAD patients. ChC patients were younger and more often women than CAD patients.

摘要

相似文献

1
Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy.
Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 2):202-5. doi: 10.1111/j.1540-8159.1999.tb00333.x.
2
Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?
Pacing Clin Electrophysiol. 1997 Jan;20(1 Pt 2):194-7. doi: 10.1111/j.1540-8159.1997.tb04841.x.
3
Late retesting of system performance in ICD patients without spontaneous shocks.对无自发电击的植入式心律转复除颤器(ICD)患者进行系统性能的晚期重新测试。
Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 2):197-201. doi: 10.1111/j.1540-8159.1999.tb00332.x.
4
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.特发性扩张型心肌病、动态心电图显示非持续性室性心动过速且左心室射血分数低于30%的患者植入式除颤器事件发生率。
J Am Coll Cardiol. 2002 Mar 6;39(5):780-7. doi: 10.1016/s0735-1097(01)01822-8.
5
Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.埋藏式心脏复律除颤器治疗恰加斯病性心脏病患者持续性室性心律失常:与单独胺碘酮治疗的对照组比较。
Europace. 2014 May;16(5):674-80. doi: 10.1093/europace/eut422. Epub 2014 Jan 30.
6
Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction.植入式心脏复律除颤器治疗特发性扩张型心肌病或无心肌梗死的冠状动脉疾病继发心室颤动幸存者的预后。
Am J Cardiol. 1993 Oct 15;72(12):911-5. doi: 10.1016/0002-9149(93)91106-r.
7
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
8
Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病患者的长期随访。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):750-6. doi: 10.1111/j.1540-8167.2011.02288.x. Epub 2012 Feb 21.
9
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.肥厚型心肌病合并除颤器患者的室性快速心律失常:触发因素、治疗及意义
J Cardiovasc Electrophysiol. 2017 May;28(5):531-537. doi: 10.1111/jce.13194. Epub 2017 Mar 31.
10
Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.植入式心脏复律除颤器患者室性快速性心律失常复发的临床和电生理预测因素
J Cardiovasc Electrophysiol. 2003 May;14(5):492-8. doi: 10.1046/j.1540-8167.2003.02328.x.

引用本文的文献

1
Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients.植入心脏复律除颤器后的临床病程:恰加斯病患者与缺血性心肌病患者对比
Arq Bras Cardiol. 2016 Aug;107(2):99-100. doi: 10.5935/abc.20160101. Epub 2016 Jul 11.
2
Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease.卡洛斯·查加斯的发现:回归慢性查加斯心脏病的科学构建
Arq Bras Cardiol. 2016 Jul;107(1):63-70. doi: 10.5935/abc.20160079. Epub 2016 May 24.
3
Arrhythmias in structural heart disease.
Curr Cardiol Rep. 2014 Aug;16(8):510. doi: 10.1007/s11886-014-0510-7.
4
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.慢性恰加斯病性心肌病的当前及新出现的治疗选择
Vasc Health Risk Manag. 2010 Aug 9;6:593-601. doi: 10.2147/vhrm.s8355.
5
Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy.同步心外膜和心内膜基质标测及射频导管消融作为慢性恰加斯病性心肌病室性心动过速和频繁植入式心律转复除颤器电击的一线治疗方法。
J Interv Card Electrophysiol. 2009 Dec;26(3):195-205. doi: 10.1007/s10840-009-9433-4. Epub 2009 Sep 15.